-
Momentum Stocks: BioLineRx, (NASDAQ:BLRX), Atossa Genetics (NASDAQ:ATOS), Norwood Financial Corp. (NASDAQ:NWFL), Lloyds Banking Group plc (NYSE:LYG), Intercontinental Hotels Group (NYSE:IHG)
On Friday shares of BioLineRx, Ltd. (NASDAQ:BLRX) closed at $2.02. On May 11, BioLineRx Ltd. (NASDAQ:BLRX) announced that it will release its unaudited financial results for the quarter ended March 31, 2015 on Monday, May 18, 2015, before the U.S. markets open. Atossa Genetics, Inc. (NASDAQ:ATOS) in last trading activity moved down -5.41% to close…
-
5 Active Stocks: Xilinx Inc. (NASDAQ:XLNX), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Atossa Genetics (NASDAQ:ATOS), NeuStar (NYSE:NSR), Arena Pharmaceuticals (NASDAQ:ARNA)
Xilinx Inc. (NASDAQ:XLNX) on 5 March 2015, announced immediate availability of the winter 2015 edition of its award-winning user magazine, Xcell Journal. The cover story for the 90th issue of Xcell Journal takes a system-level look at Xilinx’s newly unveiled UltraScale+™ product portfolio of FPGAs, 3D ICs, and MPSoCs, and how the portfolio yields a…
-
Why Investor’s Are Watching: Atossa Genetics (NASDAQ:ATOS), Hercules Offshore (NASDAQ:HERO), Wal-Mart Stores Inc. (NYSE:WMT), eBay Inc. (NASDAQ:EBAY), General Motors (NYSE:GM)
On February 27, Atossa Genetics Inc (NASDAQ:ATOS) announced that its subsidiary, The National Reference Laboratory for Breast Health (the NRLBH), has received accreditation from the College of American Pathologists (CAP), which is awarded to facilities that meet the highest standards of excellence in quality laboratory practices. On Tuesday shares of Atossa Genetics, Inc. (NASDAQ:ATOS) closed…
-
Stocks Gaining Momentum: Oncothyreon Inc (NASDAQ:ONTY), Atossa Genetics (NASDAQ:ATOS), EZCORP (NASDAQ:EZPW), Cross Country Healthcare (NASDAQ:CCRN), Alliance Data Systems (NYSE:ADS)
Oncothyreon Inc. (NASDAQ:ONTY) announced that Robert Kirkman, M.D., President and Chief Executive Officer, is scheduled to present at Cowen and Company 35th Annual Healthcare Conference on Wednesday, March 4, 2015 at 8:40 a.m. ET in Boston. On Monday shares of Oncothyreon Inc (NASDAQ:ONTY) closed at $1.62. On 27 February, Atossa Genetics Inc. (NASDAQ: ATOS), announced…
-
Investor’s Choice: Atossa Genetics (NASDAQ:ATOS), CBS Corporation (NYSE:CBS), Rite Aid Corporation (NYSE:RAD), Essex Rental Corp. (NASDAQ:ESSX), Galena Biopharma (NASDAQ:GALE)
On February 27, Atossa Genetics Inc (NASDAQ:ATOS) announced that its subsidiary, The National Reference Laboratory for Breast Health (the NRLBH), has received accreditation from the College of American Pathologists (CAP), which is awarded to facilities that meet the highest standards of excellence in quality laboratory practices. On Friday shares of Atossa Genetics, Inc. (NASDAQ:ATOS) closed…
-
Notable Moves: Atossa Genetics (NASDAQ:ATOS), National Bank of Greece (NYSE:NBG), Zynga (NASDAQ:ZNGA), Lawson Products (NASDAQ:LAWS), Fortune Brands Home & Security (NYSE:FBHS)
On February 9, Atossa Genetics Inc. (NASDAQ:ATOS) said that it has signed an agreement with Thermo Fisher Scientific for distribution of Atossa’s FullCYTE Breast Aspirator device in the United States through the Fisher HealthCare channel. Atossa’s FullCYTE Breast Aspirator is used by physicians and nurses to collect nipple aspirate fluid from a patient’s breasts for…
-
Investors Are Gambling: Ambassadors Group Inc. (NASDAQ:EPAX), Atossa Genetics (NASDAQ:ATOS), Agios Pharmaceuticals (NASDAQ:AGIO), Bristol-Myers Squibb Company (NYSE:BMY), TransAct Technologies (NASDAQ:TACT)
Ambassadors Group Inc. (NASDAQ:EPAX) announced its results for the fourth quarter and full year ended December 31, 2014. Gross revenue from continuing operations, including non-directly delivered programs, of $99.5 million during 2014 compared to $112.2 million in the prior year. During 2014, the Company traveled 16,092 delegates compared to 18,251 delegates in the same period…
-
Stocks Buzz: Atossa Genetics (NASDAQ:ATOS), Baidu Inc (NASDAQ:BIDU), BlackRock Virginia Municipal Bond Trust (NYSEMKT:BHV), Veeva Systems (NYSE:VEEV), Central Pacific Financial (NYSE:CPF)
Atossa Genetics, Inc. (NASDAQ:ATOS) signed an agreement with Thermo Fisher Scientific (NYSE: TMO) for distribution of Atossa’s FullCYTE Breast Aspirator device in the United States through the Fisher HealthCare channel. Atossa’s FullCYTE Breast Aspirator is used by physicians and nurses to collect nipple aspirate fluid from a patient’s breasts for cytological analysis. On Tuesday shares…